Significant Ownership of INCYTE CORP

Signature - Title
/s/ Sheila A. Denton - Sheila A. Denton / Executive Vice President and General Counsel
Location
Wilmington, DE
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by INCYTE CORP.

Notify me when INCYTE CORP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of INCYTE CORP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRLD Prelude Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $6,295,859 4,372,124 INCYTE CORP 03 Nov 2025

Schedules 13D/G Reported by INCYTE CORP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.